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Abstract The cation-independent mannose-6-phosphatelinsulin- 
like growth factor II receptor has been observed to bind to soluble 
forms of glycosyl-phosphatidylinositol-linked molecules, one of 
mammalian origin (rat Thy-1) and two of protozoan origins. Of 
the two phosphate groups found on the soluble forms of the 
protozoan glycosyl-phosphatidylinositol-linked molecules: (i) the 
internal mannose-6-phosphate di ster (which forms a part of the 
ethanolamine bridge) and (ii) the inositol-l,2 cyclic phosphate 
group (which arises after cleavage of the membrane associated 
form with phosphatidylinositol-specific phospholipase C), only 
the former appears to be recognized by the mannose-6-phosphate/ 
insulin-like growth factor II receptor, as mild acid hydrolysis 
which destroys the latter has been observed not to affect the 
receptor binding site. 
Key words: Mannose-6-phosphate/insulin-like growth factor II 
receptor; Glycosyl-phosphatidylinositol-linked molecule; 
Phosphatidylinositol-specific phospholipase C; Cell growth 
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1. Introduction 
The cation-independent mannose-6-phosphate receptor is a 
type I transmembrane protein involved in the targeting of 
newly synthesized, mannose-6-phosphorylated lysosomal en- 
zymes to lysosomes (for review see [1,2]). This receptor has been 
shown to recycle between the prelysosomal/endosomal com- 
partment and the cell surface, where it occurs in association 
with clathrin-coated pits [3,4]. Molecular cloning of the man- 
nose-6-phosphate receptor [5] and the insulin-like growth fac- 
tor II receptor [6] led to the conclusion that the two receptor 
functions are on the same protein [7 9], which is referred to 
here as the MPR. These findings raised the intriguing possibil- 
ity [10] that the responses of this growth-regulatory molecule 
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could be influenced by interactions with carbohydrates on 
neighbouring molecules, and lent weight to the proposal [11] 
that there may exist growth-regulating etworks based on car- 
bohydrate-protein interactions. 
The extracellular domain of the MPR contains 15 contiguous 
domains with sequence identities of 16-38% [12]. Evidence has 
been presented that the binding sites for IGF-I I  and mannose- 
6-phosphate on the MPR are distinct [13,14] and that there are 
only two mannose-6-phosphate binding sites [15], one of which 
is located within domains 1 3 and the other, domains 7-10/11. 
Therefore, the majority of the 15 repeating domains of the 
MPR may not be involved in mannose-6-phosphate binding 
[16]. In the course of a search for additional saccharide ligands 
that may be recognized by these other domains of the MPR, 
we have performed binding studies (P.G. and T.F., unpublished 
observations) using a diverse array of structurally defined lipid- 
linked oligosaccharides, ncompassing eutral and acidic oligo- 
saccharide sequences that occur commonly on N- and O-glyco- 
sylated proteins, polysaccharides and glycolipids [17 19]. 
Among these binding was detected, as predicted, to the neogly- 
colipid of the 6-phosphorylated pentamannose oligosaccharide 
derived from Hansenula holstii phosphomannan [19,20]. Bind- 
ing was also detected to the soluble form of variant surface 
glycoprotein (sVSG) from Trypanosoma brucei, which was gen- 
erated by digestion of the glycosyl-phosphatidylinositol (GPI)- 
linked molecule by phosphatidylinositol-specific phospholipase 
C (PI-PLC). 
GPI-linked molecules contain at least wo phosphate groups 
(Fig. 1), one as part of the internal mannose-6-phosphate etha- 
nolamine bridge; the other connects the glycan to the lipid 
moiety in intact GPI-linked molecules, or it is a part of an 
inositol-l,2 cyclic phosphate group in GPI-linked molecules 
that have been cleaved with PI-PLC. In view of the role of the 
MPR as a growth-regulatory molecule and the observation that 
under certain circumstances GPI-linked molecules may medi- 
ate cell signalling [21], we have pursued further our initial ob- 
servation on the binding of the receptor to a GPI-linked mole- 
cule. In particular, our aim has been to determine which of 
these two phosphate groups (P1 or P2, in Fig. 1) is involved in 
the recognition by the MPR. 
Abbreviations: BSA, bovine serum albumin; ECL, enhanced chemilu- 
minescence; GPI, glycosyl-phosphatidylinositol; IGF-II, insulin-like 
growth factor II; MPR, cation-independent mannose-6-phosphate/in- 
sulin-like growth factor II receptor; mf, membrane form of GPI-an- 
chored protein; PBS, phosphate-buffered saline (10 mM phosphate 
buffer in 140 mM NaCI pH 7.4); PI-PLC, phosphatidylinositol-specifie 
phospholipase C; PPME, phosphomannosyl ester; s, soluble form of 
GPI-anchored protein; TBS, Tris-buffered saline (10 mM Tris-HC1 in 
140 mM NaCI); VSG, variant surface glycoprotein. 
2. Materials and methods 
2.1. Cation-independentmannose-6-phosphate/insulin-likegrowthfactor 
H receptor 
A mono-disperse preparation of the 205 kDa, cation-independent 
mannose-6-phosphate/insulin-like growth factor II receptor (MPR) 
was made from fetal calf serum using a phosphomannosyl ester 
(PPME) adsorbent [22]. For radioiodination using iodogen from Sigma 
Chemical Co., Poole, Dorset, UK [23], 50/2g of the protein (estimated 
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using the Bio-Rad Protein Assay Dye Reagent Concentrate with bovine 
serum albumin (BSA) as the standard) was precipitated in 80% (v/v) 
acetone to remove sodium chloride and sodium azide preservative. 
2.2. GPI-anchored proteins 
GPI-anchored proteins were prepared as follows, in their intact mem- 
brane forms (mf) lacking the cross-reacting determinant (CRD) or as 
PI-PLC cleaved, soluble forms (s) which express the CRD. The soluble 
form of VSG (sVSG), variant MITatl.4, was purified from blood- 
stream form Trypanosoma brucei as described previously [24]. Whole 
T. brucei (variant MITat1.4) cell lysates (5 x 108 cells/ml) containing the 
membrane form of the VSG (mfVSG) or sVSG were prepared as de- 
scribed in [25]. In some experiments, mfVSG was converted to sVSG 
in situ, after electro-transfer onto nitrocellulose (as described below), 
by treating the nitrocellulose membranes with a recombinant Bacillus 
thuringiensis PI-PLC (Oxford Glycosystems, Abingdon, Oxon, UK), 2 
IU/ml in phosphate-buffered saline (PBS) for 1 h at 20°C. In other 
experiments, purified sVSG was subjected to mild acid hydrolysis in 
situ, after electro-transfer onto nitrocellulose, by soaking the nitrocellu- 
lose membranes in 1 M HC1 for 1 h at 20°C [25]. In both cases, 
nitrocellulose membranes were washed three times in PBS prior to 
further processing. 
The membrane form of Leishmania major Gp63 (mfGp63, also 
known as promastigote surface protease) was purified as in [26] and was 
a gift from Dr. Pascal Schneider. The soluble form of Gp63 (sGp63) 
was prepared by treating mfGp63 with recombinant B. thuringiensis 
PI-PLC (Oxford Glycosystems) for 4 h at 37°C in Tris-buffered saline 
(TBS), pH 8.0 using 0.5 IU of enzyme per 5/.tg of protein in a total 
volume of 10-20/A. 
The membrane form of rat brain Thy-I antigen (mtThy-1) was a gift 
of Dr. Neil Barclay. The soluble form ofThy-1 (sThy-l) was prepared 
by treating mfI'hy-1 with recombinant B. thuringiensis PI-PLC, as de- 
scribed above. 
2.3. Polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate-polyacrylamide gel lectrophoresis (SDS- 
PAGE), was performed [27] using 6% (w/v) polyacrylamide under non- 
reducing conditions for MPR, and 12% (w/v) polyacrylamide under 
reducing conditions for the GPI-anchored proteins. 
2.4. Binding assays 
Binding of ~25I-labelled MPR was evaluated to GPI-anchored pro- 
teins after SDS-PAGE and electro-transfer onto nitrocellulose [28], 
using a 1 /.tl spot (1 /tg) of PPME as a positive control. Prior to 
overlaying with the radioiodinated protein, the blots were soaked for 
2 h at 20°C in 3% (w/v) BSA in PBS. The nitrocellulose was overlaid 
for 2 h at 20°C with [~25I]MPR (5 x 105 cpm/ml) in the absence or 
presence of various inhibitors as indicated in the figure legends. The 
nitrocellulose was washed in PBS, dried and radiobinding was detected 
by autoradiography. Replicate lanes were stained with amido-black to 
reveal electro-transferred proteins. 
For detecting the CRD on GPI-anchored proteins that have been 
cleaved by PI-PLC (in solution (Gp63 and Thy-1) or on nitrocellulose 
membranes (VSG)), the electro-transferred proteins, treated with 3% 
(w/v) BSA in PBS on the membranes, were overlaid with anti-CRD 
(polyclonal rabbit IgG antibodies (1.5 #g/ml) which were raised against 
a different sVSG variant (ILTatl.21) and absorbed with mfVSG, from 
Oxford Glycosystems), and washed according to the manufacturer's 
instructions. Bound antibodies were detected with anti-rabbit IgG con- 
jugated to horseradish peroxidase (Sigma), 1 : 1000 dilution, for 1 h at 
20°C. After three washes the nitrocellulose was subjected to enhanced 
chemiluminescence, ECL (Amersham International p c., Little Chal- 
font, Bucks, UK) according to the manufacturer's instructions. 
3. Results and discussion 
In binding experiments using the radioiodinated monodis- 
perse MPR (Fig. 2) an interaction was observed with sVSG 
which had been electro-transferred onto nitrocellulose (Fig. 3, 
lane 1). The binding appeared to have a mannose-6-phosphate 
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Fig. I. The consensus structure of a GPI-anchor is shown (top) together with the product of PI-PLC digestion (bottom). All GPl-anchors contain 
an ethanolamine phosphate bridge (P1), in mannose-6-phosphate diester linkage, and a phosphate group (P2) linking the inositol to the lipid anchor. 
Protozoal GPI-anchors, such as those of T. brucei VSG and L. major Gp63, do not contain additional ethanolamine phosphate groups. Mammalian 
GPI-anchors generally contain second ethanolamine phosphate group (P3) in a mannose-2-phosphate diester linkage, and may also contain an 
additional ethanolamine phosphate group (P4) in a mannose-6-phosphate diester linkage. The groups Rz and R2 are variable carbohydrate substit- 
uents, R 3 is a fatty acyl chain and R 4 is either a fatty acyl chain or a fatty alkyl chain. 
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Fig. 2. SDS-polyacrylamide g l electrophoresis of MPR. The purifica- 
tion of MPR was as described in section 2. The protein was electro- 
phoresed under non-reducing conditions ina 6% (w/v) polyacrylamide 
gel. Unlabelled proteins (lanes 1 and 2) were visualized using silver stain 
[48]; the radiolabelled MPR was visualized by autoradiography. Lane 
1 shows molecular mass markers: myosin (205 kDa), fl-galactosidase 
(116 kDa), phosphorylase B (97 kDa), BSA (66 kDa), ovalbumin (45 
kDa) and carbonic anhydrase (29 kDa). DF = dye front of gel. Lane 
2 contained the purified MPR (1 /lg); lane 3, autoradiograph of 
[]25I]MPR (1 × 10 6 cpm). 
specificity in accord with existing knowledge: like the binding 
to PPME, the binding to sVSG was inhibited in the presence 
of mannose-6-phosphate (Fig. 3, lane 2); the binding was not 
inhibited by galactose-6-phosphate, nd there was no sugges- 
tion of specificity towards the monosaccharides mannose or 
galactose, both of which are present on this variant of VSG 
(Fig. 3, lanes 3-5). 
The MPR bound to the soluble form of a second parasite- 
derived GPI-linked protein, Gp63 from L. major (Fig. 4A, lane 
2') and also to the soluble form of rat Thy-1, a mammalian 
GPI-linked protein (Fig. 4B, lane 4). Binding to both glycopro- 
teins was inhibitable by mannose-6-phosphate (r sults not 
shown). With all three of the GPI-linked molecules investigated 
there was no binding of the MPR to the membrane forms; 
results for mfGp63 are in Fig. 4A, lane 1', those for mfVSG and 
mlThy-1 are in Fig. 4B, lanes 1 and 3, respectively. 
When soluble GPI-linked proteins are produced by PI-PLC 
cleavage, an inositol-l,2 cyclic phosphate group is generated 
(P2 in Fig. 1). The CRD is an obligatory component of an 
epitope common to all GPI-linked proteins cleaved by this 
method [29 33]. Thus, anti-CRD antibodies bind only to solu- 
ble forms and not to membrane forms of GPI-linked molecules, 
as shown for Gp63 in Fig. 4A, lanes 1 and 2. When mfVSG was 
converted to sVSG by PI-PLC treatment whilst immobilized on 
nitrocellulose, the CRD was generated (Fig. 4D, lane 1'), how- 
ever, binding to MPR was not observed (Fig. 4D, lane 1). This 
suggests that mfVSG when cleaved by PI-PLC whilst on the 
nitrocellulose is in a suitable orientation to be bound by anti- 
CRD antibodies but not by the MPR. Second, the results ug- 
gest that the inositol-l,2 cyclic phosphate group is not the 
recognition site for the MPR, rather the determinant recog- 
nized is the internal mannose-6-phosphate diester. This would 
be in accord with previous observations that MPR binds to 
mannose-6-phosphate di sters that occur on lysosomal en- 
zymes of the slime mould Dictyostelium diseoideum [15,34]. This 
idea is supported by the results of an experiment inwhich sVSG 
was subjected to mild acid hydrolysis to convert he inositol-1,2 
cyclic phosphate to inositol-l-phosphate and inositol-2-phos- 
phate and, hence destroy the CRD, leaving the remainder of 
the sVSG intact [25]. Fig. 5 shows that even after successful 
destruction of the CRD (lanes 1' and 2'), the MPR is able to 
bind to sVSG (lanes 1" and 2"). Amido black protein staining 
showed that the sVSG remained on the nitrocellulose after the 
mild acid hydrolysis (lanes 1 and 2). 
These results indicate that the recognition element for MPR 
on sVSG is the mannose-6-phosphate diester. The diester group 
is present in both soluble and membrane forms of GPI-linked 
molecules and the results of the PI-PLC cleavage xperiment 
(Fig. 4D) indicate that the accessibility of this mannose-6-phos- 
phate diester may be modulated by the orientation or mode of 
presentation of the glycoprotein. There is a precedent for this 
type of phenomenon: inherently alkali-labile fatty acid ester 
linkages on GPI-anchors are remarkably resistant o alkali 
when membrane form GPI-anchored proteins are electro- 
transferred to nitrocellulose [25]. Given that some highly-glyco- 
sylated GPI-anchored proteins bind exclusively via their lipid 
moiety [35] it seems likely that most membrane form GPI- 
proteins are oriented with their GPI anchors in contact with the 
nitrocellulose membrane. Assuming that this orientation is 
maintained after PI-PLC cleavage of mfVSG on the membrane 
(by adjacent protein nitrocellulose contacts), steric constraints 
may prevent the MPR from reaching the mannose-6-phosphate 
diester in this case. In contrast, sVSG is likely to bind in a 
relatively random fashion and therefore present most of the 
mannose-6-phosphate diester groups in a less constrained man- 
ner. Thus, although we were unable to demonstrate an interac- 
tion between MPR and membrane form GPI-linked molecules 
when immobilized on nitrocellulose membranes, it remains pos- 
sible that under certain circumstances in vivo, the membrane 
forms of GPI-linked molecules are accessible to the MPR. 
It should be noted that while protozoal GPI-proteins have 
been used here to distinguish the relative contributions of man- 
nose-6-phosphate di ster and inositol-l,2 cyclic phosphate, all 
1 2 3 4 5 
Fig. 3. Binding of [125I]MPR to purified sVSG in the absence and 
presence of inhibitors, sVSG (5/~g) was electrophoresed under educing 
conditions in a 12% (w/v) SDS-polyacrylamide g l, electro-transferred 
onto nitrocellulose and overlaid with [lZSI]MPR (5 × 10 5 cpm/ml) in the 
absence (lane 1) or presence of the following inhibitors (all at 10 mM): 
mannose-6-phosphate (lane 2), galactose-6-phosphate (lane 3), man- 
nose (lane 4) and galactose (lane 5). Binding was detected by autoradi- 
ography. A 1/tg spot of PPME (arrowed) was placed onto the nitrocel- 
lulose prior to being overlaid with [125I]MPR, as a positive control. 
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Fig. 4. Binding of [125I]MPR to soluble GPI-linked molecules, but not 
to their membrane forms. Mf and s forms of Gp63, VSG (present in 
whole-cell ysates) and Thy-1 (5 pg each) were electrophoresed, trans- 
ferred onto nitrocellulose and variously treated as follows. In panel A, 
mfand sGp63 lanes 1' and 2', respectively, were overlaid with [t25I]MPR 
and binding was detected by autoradiography; thereafter the same lanes 
(1 and 2) were overlaid with polyclonal anti-CRD antibodies, and 
binding detected using ECL. In panel B, mf and sVSG (lanes 1 and 2, 
respectively) and mf and sThy-1 (lanes 3 and 4, respectively) were 
overlaid with [~25I]MPR and binding detected by autoradiography. In 
panel C, which was a control experiment for panel D, mf and sVSG 
(lanes 1 and 2, respectively) were tested for binding to [~251]MPR; 
duplicate lanes (1' and 2', respectively) were tested for binding to anti- 
CRD antibodies using ECL. In panel D, mf and sVSG (lanes 1 and 2, 
respectively) were treated on the nitrocellulose with PI-PLC as de- 
scribed in section 2 and tested for binding to [~25I]MPR; duplicate (lanes 
1' and 2', respectively) were similarly treated with PI-PLC and tested 
for binding to anti-CRD antibodies. Note: the weak binding of the 
anti-CRD antibodies in panel C, lane 1' is due to a small amount of 
sVSG in the cell lysate containing predominantly mfVSG. The anti- 
CRD positive bands een below and above the sVSG band in panel C, 
lane 2' and panel D, lane 2' are due to some proteolysis and aggregation 
of the sVSG. 
higher eukaryote GPI-anchors contain additional ethanolam- 
ine phosphate groups, reviewed in McConville and Ferguson 
[36] (see P3 and P4, Fig. 1). Thus all of the mammalian GPI- 
anchors contain a mannose-2-phosphate diester and many, e.g. 
human erythrocyte acetylcholinesterase [37] and human CD 52 
(Truemann, Lifely, Schneider and Ferguson, unpublished data) 
contain an additional mannose-6-phosphate diester on a pro- 
portion of their GPI-anchors. While the mannose-2-phosphate 
diester is unlikely to be a ligand for the MPR, there is a possi- 
bility that some anchors (those bearing two mannose-6-phos- 
phate diesters) could simultaneously ligate two MRP mannose- 
6-phosphate binding sites, in either an intermolecular o intra- 
molecular manner. It has been postulated [38] that the well 
documented phenomenon of transmembrane signalling via the 
clustering of GPI-anchored proteins with antibodies and sec- 
ondary antibodies may involve a transmembrane protein that 
can sense this clustering. Thus there is the possibility that, in 
cells that express MPR on their surface, such as the BW5147 
T cell lymphoma [3] which is also responsive to GPI-mediated 
signals, clustered GPI-l inked proteins could form networks 
with MPR molecules and that such a co-clustering of trans- 
membrane MPR might be responsible for transmembrane sig- 
nalling in some circumstances. Other transmembrane proteins 
have been suggested to associate with GPI-anchored proteins 
and, in some cases, to possibly mediate transmembrane sig- 
nalling following the clustering of the GPI-anchored proteins. 
These include caveolin [39,40], the T-cell receptor/CD3 com- 
plex [41,42] and the complement receptor type 3 (CR3) [43,44]. 
Thus, while the physiological significance of transmembrane 
signalling via the artificial clustering of GPI-anchored proteins 
remains unclear, the transducing machinery may vary accord- 
ing to the GPI-protein in question and the cell type it is ex- 
pressed in. 
Experiments carried out using kidney basolateral membranes 
have shown that mannose-6-phosphate containing peptides 
may activate the MPR in the absence of insulin-like growth 
factor II ( IGF-II) [45,46]. Others [47] have proposed that man- 
nose-6-phosphate containing peptides per se do not have the 
ability to activate the MPR, and that activation of the receptor 
by IGF- I I  is blocked by occupancy of the mannose-6-phos- 
phate binding sites. It is possible that this binding may uncouple 
a growth regulatory network by displacing mannose-6-phos- 
phate containing endogenous proteins. Whatever the mecha- 
nism involved, there appears to be a role for mannose-6-phos- 
phate as a modulator of IGF- I I  signal transduction i vivo. The 
observations described here on the interactions between the 
MPR and the mannose-6-phosphate diester of soluble GPI- 
linked molecules open the way to further investigations, and in 
particular as to whether this binding can modulate the function 
of the MPR as a growth regulator. 
1 2 1' 2' 1"2"  
Fig. 5. Binding of [125I]MPR to sVSG (present in whole-cell lysates) 
before and after acid hydrolysis to destroy the CRD. Multiple lanes of 
sVSG were electrophoresed and electro-transferred to nitrocellulose as
described in Fig. 3. Native sVSG (lanes 1, 1' and 1") or sVSG mild acid 
treated on the nitrocellulose (lanes 2, 2' and 2") were stained with amido 
black (lanes 1 and 2) or overlaid with anti-CRD antibodies and devel- 
oped using ECL (lanes 1' and 2') or overlaid with [125I]MPR and binding 
detected by autoradiography (lanes 1" and 2"). 
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